TherapeuticsMD, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
TXMD on Nasdaq
Industry
Pharmaceutical Preparations
Location
951 Yamato Road, Suite 220, Boca Raton, Florida

Insiders trading volume in the past year

TherapeuticsMD, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John C.K. Milligan IV Secretary/CEO of subsidiary $12.7M May 10, 2021
Hugh O'Dowd Chief Executive Officer $7.73M Mar 31, 2022
Rubric Capital Management LP Director, Other*, 10%+ Owner $6.72M Nov 15, 2023
Robert G. Finizio CEO, Director $2.72M Jul 1, 2021
James DArecca Chief Financial Officer $1.86M Aug 10, 2021
Edward Borkowski EVP, Operations $679K Jul 1, 2021
J. Martin Carroll Director $239K Aug 10, 2021
Marlan D. Walker Chief Executive Officer $140K -$43.7K -23.8% Dec 5, 2023
Michael C. Donegan Prin. Fin. and Acctg. Officer $138K Apr 12, 2023
Cooper C. Collins Director $90.2K +$9.14K +11.3% Aug 22, 2024
Brian Bernick Co-Chief Executive Officer $47.1K Dec 6, 2022
Tommy G. Thompson Director $30.9K Jul 17, 2023
Gail Naughton Director $30.9K Jul 17, 2023
Angus C. Russell Director $18.2K Sep 29, 2022
Karen Ling Director $18.2K Sep 29, 2022
Jules A. Musing Director $18.2K Sep 29, 2022
Paul Bisaro Director $18.2K Sep 29, 2022
Joseph Ziegler Principal Financial Officer $16.8K Aug 17, 2023
Mark A. Glickman Co-Chief Executive Officer $15.5K Dec 6, 2022
Justin Hunter Roberts Director Aug 23, 2022

Recent Insider Transactions by Companies or Individuals for TherapeuticsMD, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.